Clinical Trial Update: Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating the efficacy and safety of topical 1% medroxyprogesterone for healing of the corneal epithelium after photorefractive keratectomy (P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Photorefractive Keratectomy-related Corneal Epithelial Healing Impairment

Drugs mentioned

• Medroxyprogesterone 1% topical (medroxyprogesterone)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Photorefractive Keratectomy | Phase 2, Phase 3 | Status: COMPLETED